ArticleHealth affairs (Project Hope)2018
Medicaid Eligibility Expansions May Address Gaps In Access To Diabetes Medications.
Article in Health affairs (Project Hope), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 33 citations in OpenAlex.
- Insulin Costs and Use by Medicare Beneficiaries After the Inflation Reduction Act Out-of-Pocket Cap.JAMA · 2026Article
- Medicaid Expansion and Medication Use Among U.S. Children with ASD or ADHD: A Repeated Cross-Sectional Analysis Comparing Before and During the COVID-19 Periods.Healthcare (Basel, Switzerland) · 2026Article
- Evaluating the impact of the Medicaid expansion program on diabetes hospitalization.Journal of public health policy · 2024Article
- Article
- Results of Leveraging Pharmaceutical Patient Assistance Programs to Expand Access to High Cost Medications in a Student-Run Free Clinic.Journal of community health · 2023Article
- Diabetes Prevalence and Incidence Inequality Trends Among U.S. Adults, 2008-2021.American journal of preventive medicine · 2023Article
- Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study.Annals of internal medicine · 2023Article
- Role of Subsidized Coverage Eligibility in Medication Adherence Among Patients With Hypertension and Diabetes: Evidence From the NHIS 2011-2018.AJPM focus · 2022Article
- Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients.JAMA network open · 2022Article
- Long-Term Effectiveness of the TIME Intervention to Improve Diabetes Outcomes in Low-Income Settings: a 2-Year Follow-Up.Journal of general internal medicine · 2022Article
- Changes in diabetes prescription patterns following Affordable Care Act Medicaid expansion.BMJ open diabetes research & care · 2021Article
- Association of Medicaid Expansion With 5-Year Changes in Hypertension and Diabetes Outcomes at Federally Qualified Health Centers.JAMA health forum · 2021Article
- Impact of Expanded Medicaid Eligibility on the Diabetes Continuum of Care Among Low-Income Adults: A Difference-in-Differences Analysis.American journal of preventive medicine · 2021Article
- Medicaid Expansion Increased Preconception Health Counseling, Folic Acid Intake, And Postpartum Contraception.Health affairs (Project Hope) · 2020Article
- Coverage for Adults With Chronic Disease Under the First 5 Years of the Affordable Care Act.Medical care · 2020Article
- The Impact of Medicaid Expansion on Diabetes Management.Diabetes care · 2020Article
- Medicaid Expansion and Mechanical Ventilation in Asthma, Chronic Obstructive Pulmonary Disease, and Heart Failure.Annals of the American Thoracic Society · 2019Article
- Diabetes management in the context of social needs: A qualitative process evaluation from care team members' perspectives.Health care management reviewArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 2 countries.
Funding
Abstract
Diabetes is a top contributor to the avoidable burden of disease. Costly diabetes medications, including insulin and drugs from newer medication classes, can be inaccessible to people who lack insurance coverage. In 2014 and 2015 twenty-nine states and the District of Columbia expanded eligibility for Medicaid among low-income adults. To examine the impacts of Medicaid expansion on access to diabetes medications, we analyzed data on over ninety-six million prescription fills using Medicaid insurance in the period January 2008-December 2015. Medicaid eligibility expansions were associated with thirty additional Medicaid diabetes prescriptions filled per 1,000 population in 2014-15, relative to states that did not expand Medicaid eligibility. Age groups with higher prevalence of diabetes exhibited larger increases. The increase in prescription fills grew significantly over time. Overall, fills for insulin and for newer medications increased by 40 percent and 39 percent, respectively. Our findings suggest that Medicaid eligibility expansions may address gaps in access to diabetes medications, with increasing effects over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.